Oxcarbazepine Tablet, Film Coated
Product Images NDC 63629-3816

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 63629-3816). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl636293816

This appears to be a product label for a medication called Trileptal 150MG Tablet. It includes information about the manufacturer (Nexgen Pharma, Inc.), package details (#30 EXP MM/YY, NDC number), and instructions for storage and keeping the drug out of reach of children. The label also includes a barcode.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Chemical Structure (Oxcarbazepine 02)

The text describes statistical test results for the "Exit rate" with a p-value of 0.0001. There is also a plot showing the "Time on trial" for Placebo from Day 2 to Day 11.*

FDA Label Image

Chemical Structure (Oxcarbazepine 03)

This is a graph that represents the seizure rate of two groups of patients over a period of 140 days. The treatment group was given oxcarbazepine and the control group was given a placebo. The log-rank test suggests a statistically significant difference between the two groups with a p-value of 0.046. The X-axis shows the days from the first dose to the first seizure and the Y-axis is not provided.*

FDA Label Image

Chemical Structure (Oxcarbazepine 04)

This text is displaying results of a log-rank test and a graph showing the time to exit for a treatment group. It is not possible to provide a further description without additional context or information.*

FDA Label Image

Chemical Structure (Oxcarbazepine 05)

The text describes the results of a log-rank test with a p-value of 0.0001, but the context of the analysis is not given. The graph shows the time to exit in days for a treatment group designated as "HIGH" and a comparison group designated as "LOW" at various time points up to 130 days.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.